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Dear editor;
Early postpartum follow-up of women with a history
of gestational diabetes mellitus (GDM) provides an op-
portunity to assess health condition of mothers as well
as their offspring health [1]. GDM is considered as the
strongest predictor of type 2 diabetes, thus follow-up of
women with recent GDM can lead to early diagnosis
and management of diabetes and other metabolic disor-
ders outcomes [2].
In developed countries, a low postpartum return rate
of women with GDM was reported for assessment of
blood glucose [3]. In spite of high prevalence of GDM in
Iran [4], evidences about postpartum return rate of
women with this disorder and its predicators are not
documented adequately.
Given the low postpartum return rate of women with
GDM for oral glucose tolerance test and high use of mo-
bile phone in Iran, we compared the effects of two
methods of Short Message Service (SMS) text and tele-
phone contact reminders on doing of oral glucose toler-
ance test (OGTT) for diagnosis of type 2 diabetes
among women with GDM to design a novel method for
recall of postpartum follow-up. We entered all of women
with recent GDM who registered for screening of congeni-
tal hypothyroidism of their newborn early days after deliv-
ery in two main referral centers of Ahvaz, southwestern of
Iran. Totally 476 women with abnormal glucose test
in their recent pregnancy were evaluated for eligible
criteria during January to March 2015. Among those,
156 women (residents of rural area, no available la-
boratory records of glucose status during pregnancy,
cases of pregestational diabetes, early move out of
Ahvaz after parturition, women with literacy problem,
no access to mobile phone) were excluded and other
320 women that had inclusion criteria were assigned
to receive either 4 SMS texts (n= 160) or 4 telephone
contacts (n= 160) with the same dialog during 3–5
days to 6–12 weeks after delivery. SMS texts were
sent to women, their husband or both. We asked all
women in both groups to return for completion
OGTT (a 75-g 2-h oral glucose tolerance test) during
6–12 weeks after delivery. Totally, 90 women (28.12 %)
returned and performed OGTT during study period.
Among those, 55 women (34.37 %) were in telephone con-
tacts group and 35 women (21.87 %) were in SMS texts
group. We concluded that postpartum return rate was
higher in women with telephone contacts intervention.
Based on the results of this study, we continued recal-
ling of women in life after gestational diabetes Ahvaz
(LAGA) cohort study (IR.AJUMS.REC.1394.252) to
compare potential metabolic outcomes in women with
GDM (impaired glucose tolerance, diabetes type 2, lipids
abnormality and metabolic syndrome) with healthy
women. During 6 months recall from March 2015, we reg-
istered 1500 pregnant women (after 30 weeks’ gestation)
who were referred for prenatal care to Ahvaz public health
centers or Ahvaz private clinics to return for postpartum
follow-up early after delivery and 2 years afterwards, in
baseline visit. We used different methods of communica-
tion to recall women to participate. Invitation was sent via
social networks (telegram and what’s up), mobile and direct
contact via phone for women, their husband or the first rel-
atives who their phone number was available. The baseline
visit took place in 25 public and private health centers, and
eligible women were invited to refer to cohort study center
(Ahvaz Golestan hospital). Until now, data were collected
in the first 6–12 weeks after delivery and data collection
will continue until March 2017. Data collection tool in this
study is a 180-item questionnaire including socio-
demographic details, risk factors of gestational diabetes and
its potential outcomes, medical and reproductive history,
anthropometric measurements, physical activity, dietary
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intake, and breast feeding. Blood samples were collected in
6–12 weeks postpartum and will repeat annually within the
first 2 years after delivery.
After excluded 200 mothers who could not meet study
criteria, 1300 eligible women (800 women with GDM
and 500 women with normal blood glucose) enrolled.
Totally, 230 women (17.69 %) liked to participate in
postpartum follow-up. Among those, 180 women
(22.5 %) were with GDM and 50 women (10 %) were
without GDM. Of women with GDM, 40 cases (5 %)
didn’t not return to offered follow-up cohort study
center, but reported uptake a test to check their glucose
status which ordered by their physician in private clinics.
Of those, 32 women (80 %) checked their glycemic status
with fasting blood glucose (FBS) and the rest, uptake an
OGTT during first weeks after delivery. Overall, return
for follow-up and attendance for OGTT was low in early
postpartum period in both our studies. It seems that per-
ceived barriers for attendance and checking health status
of women with GDM are stronger than the perceived risk
of diabetes mellitus and other metabolic outcomes in the
future [5].
Based on our experiences, it seems that poor commu-
nication between the public and private health sectors,
inadequate referral system, lack of a national data regis-
try and integrated health information system in addition
to cultural and patient-related barriers are some chal-
lenges facing us for follow-up and lead to low rate of
follow-up. These problems with controversies in screen-
ing, treatment and others concern make this process ar-
duous. So, further research is suggested to explore the
influencing factors for postpartum attendance with dif-
ferent methods. Also, it is recommended that with using
experiences of other countries in this regard, novel strat-
egies be taken by authorities.
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